Apples and oranges: A comparison of costing methods for obesity

Obesity Reviews

Volumn 14, Issue 9, 2013, Pages 693-706

  Bierl, M ^a   Marsh, T ^a   Webber, L ^a   Brown, M ^a   Mcpherson, K ^b   Rtveladze, K ^a  

^a Modelling Dept Hlth Protect A   (United Kingdom)

^b NEW COLLEGE   (United Kingdom)

Author keywords

Cost; Modelling; Obesity; Patient attributable fraction

Indexed keywords

ARTICLE; BODY MASS; COST OF ILLNESS; DISEASE ASSOCIATION; HEALTH CARE COST; HEALTH SERVICE; HUMAN; LIFE EXPECTANCY; OBESITY; POPULATION SIZE; SYSTEMATIC REVIEW; UNITED STATES; COMORBIDITY; ECONOMICS; EPIDEMIC; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

COMORBIDITY; COST OF ILLNESS; EPIDEMICS; HEALTH CARE COSTS; HUMANS; NATIONAL HEALTH PROGRAMS; OBESITY; UNITED STATES;

EID: 84881615622     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12044     Document Type: Article

References (83)

1. Ezzati M, Stevens GA, Finucane MM, Danaei G. Global trends in body-mass index- Authors' reply. Lancet 2011; 377: 1917-1918.
2. World Health Organisation. Obesity and overweight, 2011. [WWW document]. URL http://www.who.int/mediacentre/factsheets/fs311/en/index.html (accessed 30 August 2011).
3. Colditz GW, Wang YC. Economic costs of obesity. In: Hu F (ed.). Obesity Epidemiology. Oxford University Press, Inc: New York, 2008, pp. 261-274.
4. Popkin BM, Kim S, Rusev ER, Du S, Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev 2006; 7: 271-293.
5. Huhges D, McGuire A. A review of the economic analysis of obesity. Br Med Bull 1997; 53: 253-263.
6. USDA Economic Research Service. Food Safety Glossary. Washington DC, 2010. [WWW document]. URL http://www.ers.usda.gov/emphases/safefood/glossary.htm (accessed 30 August 2011).
7. Katz DL. Competing dietary claims for weight loss: finding the forest through truculent trees. Annu Rev Public Health 2005; 26: 61-88.
8. Dor AF, Langwith C, Tan E. A heavy burden: The individual costs of being overweight and obese in the United States. The George Washington University School of Public Health and Health Services Department of Health Policy, 2010.
9. Hammond RA. Complex systems modelling for obesity research. Prev Chronic Dis 2009; 6: A96. [WWW document]. URL http://www.cdc.gov/pcd/issues/2009/jul/09_0017.htm (accessed 30 August 2011).
10. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the US and the UK. Lancet 2011; 378: 815-825.
11. Roux L, Donaldson C. Economics and obesity: costing the problem or evaluating solutions? Obes Rev 2004; 12: 173-179.
12. Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2011; 12: 131-141.
13. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff 2009; 28: w822-w831.
14. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff 2003; Suppl Web Exclusives: W3-219-226.
15. Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical spending. Health Aff 2004; Suppl Web Exclusives: W4-480-486.
16. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. 2008) Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic. Obesity (Silver Spring).
17. National Audit Office (NAO). Tackling Obesity in England. HMSO: London, 2001.
18. Lean MEJ. Clinical Handbook of Weight Management. Dunitz: London, 1998.
19. Access Economics. The Growing Cost of Obesity in 2008: Three Years on. Diabetes Australia: Canberra, 2008.
20. Ricci JA, Chee E. Lost productive time associated with excess weight in the U.S. workforce. J Occup Environ Med 2005; 47: 1227-1234.
21. Levine B. What does the population attributable fraction mean? Prev Chronic Dis 2007; 4: A14.
22. Rowe AK, Powell KE, Flanders WD. Why population attributable fractions can sum to more than one. Am J Prev Med 2004; 26: 243-249.
23. Levy DT, Mabry PL, Wang YC etal. Simulation models of obesity: a review of the literature and implications for research and policy. Obes Rev 2011; 12: 378-394.
24. Tsai AG, Williamson F, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev 2011; 12: 50-61.
25. Allender S, Rayner M. The ill health burden of overweight and obesity. Obes Rev 2007; 8: 467-473.
26. National Obesity Observatory (NOO). The economic burden of obesity. Oxford, 2010.
27. Thompson D, Wolf AM. The medical-care cost burden of obesity. Obes Rev 2001; 2: 189-197.
28. Kortt MA, Langley PC, Cox ER. A review of cost-of-illness studies on obesity. Clin Ther 1999; 20: 772-779.
29. Oster G, Edelsberg J, O'Sullivan AK, Thompson D. The clinical and economic burden of obesity in a managed care setting. Am J Manag Care 2000; 6: 681-689.
30. Yang Z, Hall AG. The financial burden of overweight and obesity among elderly Americans: the dynamics of weight, longevity, and health care cost. Health Serv Res 2008; 43: 849-868.
31. Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obes Res 2004; 12: 1936-1943.
32. Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes 2005; 29: 334-339.
33. Colagiuri S, Lee CMY, Colagiuri R etal. The cost of overweight in Australia. Med J Aust 2010; 192: 260-264.
34. Kuriyama S, Hozawa A, Ohmori K etal. Joint impact of health risks on health care charges: 7-year follow-up of National Health Insurance beneficiaries in Japan (the Ohsaki Study). Prev Med 2004; 39: 1194-1199.
35. Sturm R, Ringel JS, Andreyeva T. increasing obesity rates and disability trends. Health Aff 2004; 23: 199-205.
36. Wang G, Zheng ZJ, Heath G, Macera C, Pratt M, Buchner D. Economic burden of cardiovascular disease associated with excess body weight in U.S. adults. Am J Prev Med 2002; 23: 1-6.
37. Wolf AM, Finer N, Allshouse AA etal. PROCEED: prospective obesity cohort of economic evaluation and determinants: baseline health and healthcare utilization of the US sample. Diabetes Obes Metab 2008; 10: 1248-1260.
38. Anis AH, Zhang W, Bansback N, Guh DP, Amarsi Z, Birmingham CL. Obesity and overweight in Canada: an updated cost-of-illness study. Obes Rev 2010; 11: 31-40.
39. House of Commons Health Committee (HCHC). Obesity: third report of session 2003-04/Great Britain. Vol 1: Report, together with formal minutes/Health Committee. Parliament, London: HMSO, 2004.
40. Thompson D, Edelsberg J, Kinsey KL, Oster G. Estimated economic costs of obesity to U.S. business. Am J Health Promot 1998; 13: 120-127.
41. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Rev 1998; 6: 97-106.
42. Aitken RJ, Allman-Farinelli MA, King LA, Bauman AE. Current and future costs of cancer, heart disease and stroke attributable to obesity in Australia - a comparison of two birth cohorts. Asia Pac J Clin Nutr 2009; 18: 63-70.
43. Butland B, Jebb S, Kopelman P etal. Foresight: Tackling Obesities: Future Choices - Project report, 2007. [WWW document]. URL http://www.foresight.gov.uk/Obesity/Obesity_final/Index.html (accessed 30 August 2011).
44. Janssen I, Larn M, Katzmarzyk PT. Influence of overweight and obesity on physician costs in adolescents and adults in Ontario, Canada. Obes Rev 2009; 10: 51-57.
45. Lakdawalla DN, Goldman DP, Shang B. The health and cost consequences of obesity among the future elderly. Health Aff 2005; 24: W5R30-W5R41.
46. Lightwood J, Bibbins-Domingo K, Coxson P, Wang CY, Lawrence W, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health 2009; 99: 2230-2237.
47. Tucker DM, Palmer AJ, Valentine WJ, Roze S, Ray JA. Counting the costs of overweight and obesity: modeling clinical and cost outcomes. Curr Med Res Opin 2006; 22: 575-586.
48. van Baal PHM, Polder JJ, de Wit GA etal. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. Plos Med 2008; 5: e29.
49. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
50. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Arch Intern Med 1999; 159: 2177-2183.
51. Levin KA. Study Design III: cross-sectional studies. Evid Based Dent 2006; 7: 24-25.
52. Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 2003; 20: 54-60.
53. Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal-Bahl SJ. Indirect costs of obesity: a review of the current literature. Obes Rev 2008; 9: 489-500.
54. Jurgena J, Wenig CM, Wolfentetter S. Recent economic findings on childhood obesity: cost-of-illness and cost-effectiveness of interventions. Curr Opin Clin Nutr Metab Care 2010; 13: 305-313.
55. Stevens J. Accuracy of current, four-year, and twenty-eight-year self-reported bodyweight in an elderly population. Am J Epidemiol 1990; 132: 1156-1163.
56. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff 2002; 21: 245-254.
57. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003; 163: 2146-2148.
58. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-19.
59. Lee RH. Future costs in cost effectiveness analysis. J Health Econ 2008; 27: 809-818.
60. Finkelstein EA, DiBonaventura MD, Burgess SM, Hale BC. The costs of obesity in the workplace. J Occup Environ Med 2010; 52: 971-976.
61. McPherson K, Marsh T, Brown M. Modelling Future Trends in Obesity and the Impact on Health. Foresight - Tackling Obesities: Future Choices - Government Office for Science, 2007.
62. Mason CA, Tu S. Partitioning the population attributable fraction for a sequential chain of effects. Epidemiol Perspect Innov 2008; 5: 5.
63. Flegal K, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861-1867.
64. Hollinghurst S, Bevan G, Bowie C. Estimating the 'avoidable' burden of disease by Disability Adjusted Life Years (DALYs). Health Care Manag Sci 2000; 3: 9-21.
65. Bonabeau E. Agent-based modeling: methods and techniques for simulating human systems. Proc Natl Acad Sci U S A 2002; 99: 7280-7287.
66. Tesfatsion L, Judd KL. Handbook of Computational Economics, Vol. 2. Elseiver: North-Holland, Amsterdam, 2006.
67. Epstein JM. Remarks on the foundations of agent-based generative social science. In: Tesfatsion L, Judd KL (eds). Handbook of Computational Economics, Vol. 2. North-Holland: Amsterdam (NL), 2006, pp. 1585-1604.
68. Swinburn B, Gill T, Kumanyika S. Obesity prevention: a proposed framework for translating evidence into action. Obes Rev 2005; 6: 23-33.
69. Access Economics. The economic costs of obesity. Access Economics, Canberra, 2006. [WWW document]. URL http://www.accesseconomics.com.au/publicationsreports/getreport.php?report=102&id=139 (accessed 30 August 2011).
70. Chang VW, Christakis NA. Medical modelling of obesity: a transition from action to experience in a 20th century American medical textbook. Sociol Health Illn 2002; 23: 151-177.
71. Epstein JM. Why model? J Artificial Societies Social Simulation 2004; 11: 12-17.
72. McPherson K. Does preventing obesity lead to reduced health-care costs? Plos Med 2008; 5: e37.
73. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758-1761.
74. Lobstein T, Leach RJ. Data documentation for the Dynamic Modelling for Health Impact Assessment (DYNAMO-HIA) Project. Workpackage 7: Overweight and obesity report on data collection for overweight and obesity prevalence and related relative risks, 2010. [WWW document]. URL http://www.dynamo-hia.eu/object_binary/o3055_BMI_WP7-datareport_20100317.pdf (accessed 30 August 2011). International Association for the Study of Obesity (IASO).
75. Philips Z, Bojke L, Sculpher M, Claxton K, Golder S. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006; 24: 355-371.
76. Levy E. The Economic cost of obesity: the French situation, 1995.
77. Morgan E, Dent M. The Economic Burden of Obesity. National Obesity Observatory: Oxford, 2010.
78. Rappange DR, van Baal PHM, van Excel NJA, Feenstra TL, Rutten FFH, Brouwer WBF. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008; 26: 815-830.
79. Akobundu E, Ju J, Blatt L, Mullins CD. Cost-of-illness studies. a review of current methods. Pharmacoeconomics 2006; 24: 869-890.
80. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford University Press: Oxford, 1997.
81. Murphy C, Yates J. Economic comparison of weight loss programmes versus drug treatment for the management of obesity. Asia Pac J Clin Nutr 2005; 14(CD Suppl.): 97-105.
82. Huang TT, Glass TA. Transforming research strategies for understanding and preventing obesity. JAMA 2008; 30: 1811-1813.
83. Chou S-Y, Grossman M, Saffer H. An economic analysis of adult obesity: results from the Behavioral Risk Factor Surveillance System. J Health Econ 2004; 23: 565-587.